内镜下肌间剥离术治疗直肠神经内分泌肿瘤效果及安全性的初步评价（含视频）

Efficacy and safety of endoscopic intermuscular dissection for the treatment of rectal neuroendocrine tumors (with video)

摘要:

为了初步探讨内镜下肌间剥离术（endoscopic intermuscular dissection，EID）治疗直肠神经内分泌肿瘤（rectal neuroendocrine tumors， R⁃NETs）的效果及安全性，2022年1月至2023年10月在深圳大学附属华南医院接受EID治疗且术后病理证实为R⁃NETs的8例连续病例纳入回顾性观察，主要分析治疗效果、并发症发生情况及随访结果。结果显示8例均通过EID获得完整切除，手术时间40~90 min，无出血和穿孔，术后无发热和电凝综合征发生，术后住院4~6 d；随访3~24个月，无局部复发和转移。由此初步判断，EID治疗R⁃NETs安全、可行。

Abstract:

In order to preliminarily evaluate the efficacy and safety of endoscopic intermuscular dissection (EID) for the treatment of rectal neuroendocrine tumors (R-NETs), a retrospective observational study was conducted on 8 consecutive patients with R-NETs confirmed by postoperative pathology at South China Hospital, Medical School, Shenzhen University from January 2022 to October 2023. The therapeutic efficacy, incidence of complications, and follow-up results were mainly analyzed. The results showed that all 8 cases achieved complete resection after EID, with operation times ranging from 40 to 90 minutes. No bleeding, perforation, fever or electrocoagulation syndrome occurred after operation. The hospital stay was 4 to 6 days. During follow-up of 3 to 24 months, there was no local recurrence or metastasis. Therefore, a preliminary conclusion can be drawn that EID is a safe and feasible treatment for R-NETs.